Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol spray before general anesthesia in patients with COPD
IRCT20170108031818N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of salbutamol in chronic obstructive pulmonary disease (COPD), sponsored by Golestan University of Medical Sciences. Primary endpoints: Wheezing, Bronchospasm and 2 more. Started Nov 2021; status: completed.
02
Drugs
salbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20170108031818N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170108031818N1.